PubMed COVID-19 Clinical Care

Omicron is a novel variant of SARS-CoV-2 that is currently spreading globally as the dominant strain. The virus first enters the host cell through the receptor binding domain (RBD) of the spike protein by interacting with the angiotensin-converting

The Food, Beverage & Tobacco (F&B) industry is an essential sector in the competitive economy. Procurement of production factors mainly depends on sales forecasting and the supply chain of raw materials. However, the conflict between Russia and

Sickle cell disease is the most common hemoglobinopathy among humans. As the condition promotes susceptibility to infections, chronic inflammation, and hypercoagulability disorders, several international agencies have included individuals with this

CONCLUSION: Embedding recruitment into routine clinical care was the most influential factor on recruitment to the RECOVERY trial. To enable this, sites needed to attain the ideal recruitment situation. Prior research activity, size of site and

COVID-19 pandemic and complete lockdowns brought about major changes in the education system. There was a sudden obligatory shift toward the utilization of digital resources for teaching and learning purposes in those critical times. Medical

CONCLUSIONS: Mental well-being, lifestyle behaviors, self-management capacity, and healthcare utilization were impacted in the months following the COVID outbreak.

BACKGROUND: We evaluated the immunogenicity and safety of a booster dose of NVX-CoV2373 in Japanese adults who had completed a primary series of COVID-19 mRNA vaccine 6-12 months previously.

INTRODUCTION: Acute respiratory distress syndrome and acute lung injury (ARDS/ALI) still lack a recognized diagnostic test and pharmacologic treatments that target the underlying pathology.

CONCLUSION: The first state of emergency greatly reduced the NPVDC, NDTD, and DE compared to those in the previous year. In people aged over 65 years, it might still be unresolved 2 years after the postponement of dental treatment owing to the first

CONCLUSION: There has been a decrease in new diagnosis of most respiratory diseases during the COVID-19 pandemic.